How Moderna's Patent Challenge Loss Could Impact Coronavirus Vaccine Program
Moderna Inc (NASDAQ: MRNA) shares came under significant selling pressure Thursday afternoon following an adverse patent ruling, and the stock is adding to the losses in Friday's session.
